Qualitative Survey of Potential Exercise Activity in Adults With Sickle Cell Anemia (SCA) (SCA)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04181944 |
Recruitment Status :
Completed
First Posted : December 2, 2019
Last Update Posted : December 8, 2022
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Cardiovascular Diseases Sickle Cell Disease Exercise | Other: Exercise Treatment Group | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 115 participants |
Allocation: | N/A |
Intervention Model: | Single Group Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Other |
Official Title: | Qualitative Survey of Potential Exercise Activity in Adults With Sickle Cell Anemia (SCA) |
Actual Study Start Date : | June 14, 2020 |
Actual Primary Completion Date : | January 1, 2022 |
Actual Study Completion Date : | October 1, 2022 |

Arm | Intervention/treatment |
---|---|
Experimental: Exercise Treatment Group |
Other: Exercise Treatment Group
be specific |
- Specific exercise regimen for those living with sickle cell disease [ Time Frame: One year ]100 participants with sickle cell disease exercise preference based on the survey results, decrease the severity of cardiovascular disease in patients with sickle cell disease

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- 18 years or older with a known diagnosis of sickle cell anemia
- Subject (and, parental/legal representative, when applicable) must understand and voluntarily sign a consent form and complete an interview
Exclusion Criteria:
- Subjects who does not meet the inclusion criteria above

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04181944
United States, Florida | |
Memorial Healthcare System | |
Hollywood, Florida, United States, 33021 |
Principal Investigator: | Foluso J Ogunsile, MD | Memorial Healthcare System |
Responsible Party: | Memorial Healthcare System |
ClinicalTrials.gov Identifier: | NCT04181944 |
Other Study ID Numbers: |
SCDFit |
First Posted: | December 2, 2019 Key Record Dates |
Last Update Posted: | December 8, 2022 |
Last Verified: | December 2022 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Plan Description: | To be determined |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Cardiovascular Diseases Anemia, Sickle Cell Anemia Hematologic Diseases |
Anemia, Hemolytic, Congenital Anemia, Hemolytic Hemoglobinopathies Genetic Diseases, Inborn |